Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perspectives in pharmacogenetics.

W Kalow1

  • 1Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. w.kalow@utoronto.ca

Archives of Pathology & Laboratory Medicine
|January 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine.

The pharmacogenomics journal·2006
Same author

A simple test for acetylator phenotype using caffeine. 1984.

British journal of clinical pharmacology·2004
Same author

Both populations and individuals are evolutionary targets: pharmacogenomic and cultural indicators.

The pharmacogenomics journal·2002
Same author

Multigenic traits and risk assessment in pharmacology: a population approach.

The pharmacogenomics journal·2002
Same author

Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.

Journal of clinical psychopharmacology·2002
Same author

Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine.

European journal of clinical pharmacology·2001
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Pharmacogenetics explores how gene variations affect drug responses, highlighting both individual and population differences. Understanding monogenic and multigenic variations is key to personalized medicine.

Area of Science:

  • Pharmacogenetics
  • Genetics
  • Drug Metabolism

Background:

  • Personal historical perspective on the emergence of pharmacogenetics.
  • Initial focus on interpersonal variability in drug response.
  • Subsequent attention to interethnic differences in pharmacogenetics.

Discussion:

  • Impact of technical advancements in identifying gene alterations.
  • Comparison of monogenic (Mendelian) and multigenic (multifactorial) genetic variations.
  • Analysis of the distinct consequences of different genetic variation types.

Key Insights:

  • Pharmacogenetics evolved from observing individual variability to understanding population-level genetic differences.
  • Technological progress has enabled the identification of numerous gene variants influencing drug efficacy and safety.

Related Experiment Videos

  • Distinguishing between monogenic and multigenic influences is crucial for interpreting drug response variability.

    • Outlook:

    • Future directions in pharmacogenetic research.
    • Integration of pharmacogenetics into clinical practice.
    • Advancements in understanding complex genetic interactions in drug response.